Curis Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.96 |
Market Cap |
$59.34 M |
Shares Outstanding |
33.15 M |
Public Float |
27.18 M |
Address |
4 Maguire Road Lexington Massachusetts 02421 United States |
Employees | - |
Website | http://www.curis.com |
Updated | 07/08/2019 |
Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. |